Irfana Muqbil

Selinexor, a Selective Inhibitor of Nuclear Export (SINE) compound, acts through NF-κB deactivation and combines with proteasome inhibitors to synergistically induce tumor cell death

Trinayan Kashyap, Christian Argueta, Amro Aboukameel et al. · Oncotarget · 2016 · 132 citations · Full text

Medicine, Oncology, Pharmacology +17

Novel p21-Activated Kinase 4 (PAK4) Allosteric Modulators Overcome Drug Resistance and Stemness in Pancreatic Ductal Adenocarcinoma

Amro Aboukameel, Irfana Muqbil, William Senapedis et al. · Molecular Cancer Therapeutics · 2016 · 90 citations · Full text

Medicine, Oncology, Pharmacology +15

Regulation of renal organic anion and cation transporters by thymoquinone in cisplatin induced kidney injury

Ramazan Ulu, Ayhan Doğukan, Mehmet Tuzcu et al. · Food and Chemical Toxicology · 2012 · 78 citations

Medicine, Nephrology, Pharmacology +15

Progress in Nanotechnology Based Approaches to Enhance the Potential of Chemopreventive Agents

Irfana Muqbil, Ashiq Masood, Fazlul H. Sarkar et al. · Cancers · 2011 · 60 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Preclinical Assessment with Clinical Validation of Selinexor with Gemcitabine and Nab-Paclitaxel for the Treatment of Pancreatic Ductal Adenocarcinoma

Asfar S. Azmi, Husain Yar Khan, Irfana Muqbil et al. · Clinical Cancer Research · 2019 · 57 citations · Full text

Medicine, Oncology, Pharmacology +15